Renaissance Capital logo

Enveric Biosciences (AMERI Holdings) Priced, Nasdaq: ENVB

Outsourced provider of IT services to SAP customers.

Industry: Technology

First Day Return: -15.3%

Industry: Technology

Our SAP focus allows us to provide technological solutions to a broad and growing base of clients. Our model inverts the conventional global delivery model wherein offshore IT service providers are based abroad and maintain a minimal presence in the US. With a strong SAP focus, our client partnerships anchor around SAP cloud services, artificial intelligence, internet of things ad robotic presence automation. We pursue an acquisition strategy that seeks to disrupt the established business model of offshore IT service providers. We generate revenue by providing consulting services under written service contracts with our customers. The service contracts generally fall into two categories: (1) time-and-materials contracts and (2) fixed-price contracts.
more less
IPO Data
IPO File Date 09/18/2017
Offer Price $4.12
Price Range $4.00 - $4.50
Offer Shares (mm) 1.5
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/17/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $6
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Princeton, NJ, United States
Founded 2013
Employees at IPO 275
Website www.ameri100.com

Enveric Biosciences (AMERI Holdings) (ENVB) Performance